However, COC use is also associated with impaired fasting glucose, insulin resistance, and an elevated risk of thromboembolic events (85)
Restoring pulsatile GH release through GHS-R1a agonism could theoretically counteract this decline
For me, the answer was GLP-1s, Williams said
11 A separate and highly replicated finding is that GLP-1 RAs directly target molecular systems implicated in neurogenesis, neurodifferentiation, neuroplasticity (Neuro-GDP), neuroprotection, and apoptosis ( 12 For example, GLP-1 RAs increase synthesis of cAMP response element-binding protein (CREB), brain-derived neurotrophic factor (BDNF), and glial-derived neurotrophic factor (GDNF), proteins integral to neurotrophic processes
I am so glad I am in a clinic where I truly feel I am being heard and my thoughts matter. Tameka J.